Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brooks, J M
Right arrow Articles by Simmer, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks, J M
Right arrow Articles by Simmer, K
Archives of Disease in Childhood Fetal and Neonatal Edition 2005;90:F235-FF239
© 2005 Archives of Disease in Childhood Fetal and Neonatal Edition


ORIGINAL ARTICLE

Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management

J M Brooks1, J N Travadi1, S K Patole*1, D A Doherty2, K Simmer*1

1 Women’s and Children’s Health Service, Western Australia and *University of Western Australia
2 Women and Infants Research Foundation and University of Western Australia

Correspondence to:
Correspondence to:
Dr Patole
Department of Neonatal Paediatrics, King Edward Memorial Hospital, Bagot Road, Subiaco, Western Australia 6008; Sanjay.Patole{at}health.wa.gov.au

Background: Surgical ligation of patent ductus arteriosus (PDA) is widely practised in preterm infants despite no clear evidence that this improves outcomes. Geographical isolation meant that ductal ligation was not an option in King Edward Memorial Hospital until recently.

Objective: A retrospective data analysis to test the hypothesis that outcomes of infants with persistent PDA were no worse than those of infants with no significant duct or a duct that closed after medical treatment.

Patients and Methods: A total of 252 infants (gestation <=28 weeks) born between 1 January 2000 and 30 June 2002 were divided into three groups: group 1, no significant PDA (n = 154); group 2, significant PDA which closed after medical treatment (n = 65); group 3, significant PDA remaining patent after medical treatment (n = 33). A significant PDA was defined by a left atrium to aortic root ratio of >1.4 or a ductal diameter >1.5 mm with a left to right shunt.

Results: Twenty four (10%) infants died at median (interquartile range) 15.5 (9–35) days. After adjustment for gestational age, relative to group 1, the infants from group 3 were at a 4.02 times increased risk of death (95% confidence interval 1.12 to 14.51). There was no significant difference between groups in the incidence of chronic lung disease, chronic lung disease or death, necrotising enterocolitis, intraventricular haemorrhage, duration of oxygen, or hospital stay.

Conclusion: Mortality was higher in infants with a persistent PDA, but other morbidities were not significantly different. A randomised trial is needed to determine whether surgical ligation will reduce mortality in such infants.


Abbreviations: CLD, chronic lung disease; CRIB, clinical risk index for babies; IVH, intraventricular haemorrhage; NEC, necrotising enterocolitis; PDA, patent ductus arteriosus

Keywords: patent ductus arteriosus; surgical ligation; mortality; chronic lung disease




This article has been cited by other articles:


Home page
RadiologyHome page
A. M. Gaca, J. J. Jaggers, L. T. Dudley, and G. S. Bisset III
Repair of Congenital Heart Disease: A Primer--Part 2
Radiology, July 1, 2008; 248(1): 44 - 60.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
P. Roberts, S. Adwani, N. Archer, and N. Wilson
Catheter closure of the arterial duct in preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F248 - F250.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. Chorne, C. Leonard, R. Piecuch, and R. I. Clyman
Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity
Pediatrics, June 1, 2007; 119(6): 1165 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
S K Patole, V Kumaran, J N Travadi, J M Brooks, and D A Doherty
Does patent ductus arteriosus affect feed tolerance in preterm neonates?
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2007; 92(1): F53 - F55.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Manzar
High-Dose Indomethacin for Patent Ductus Arteriosus Closure: How Strong Is the Evidence?
Pediatrics, May 1, 2006; 117(5): 1863 - 1863.
[Full Text] [PDF]


Home page
PediatricsHome page
M. Sperandio, B. Beedgen, and O. Linderkamp
High-Dose Indomethacin for Patent Ductus Arteriosus Closure: How Strong Is the Evidence?: In Reply
Pediatrics, May 1, 2006; 117(5): 1863 - 1864.
[Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
P W Fowlie
Managing the baby with a patent ductus arteriosus. More questions than answers?
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2005; 90(3): F190 - f190.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health